ScinoPharm Taiwan Ltd (1789) — Working Capital to Net Assets Ratio
ScinoPharm Taiwan Ltd (1789) has a Working Capital to Net Assets ratio of 45.4% as of December 2025. Working capital of NT$4.78 Billion (current assets of NT$5.49 Billion minus current liabilities of NT$709.84 Million) is measured against net assets of NT$10.52 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See ScinoPharm Taiwan Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
ScinoPharm Taiwan Ltd Working Capital to Net Assets (2007–2025)
This chart shows how ScinoPharm Taiwan Ltd's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of December 2025, the ratio stands at 45.4%, reflecting working capital of NT$4.78 Billion against net assets of NT$10.52 Billion TWD. Check 1789 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for ScinoPharm Taiwan Ltd (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for ScinoPharm Taiwan Ltd from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ScinoPharm Taiwan Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.4% | NT$4.78 Billion | NT$10.52 Billion | NT$5.49 Billion | NT$709.84 Million | ▼ -10.1 pp |
| 2024 | 55.5% | NT$5.84 Billion | NT$10.53 Billion | NT$6.61 Billion | NT$767.68 Million | ▲ +1.0 pp |
| 2023 | 54.5% | NT$5.65 Billion | NT$10.36 Billion | NT$6.38 Billion | NT$729.45 Million | ▲ +1.7 pp |
| 2022 | 52.8% | NT$5.52 Billion | NT$10.45 Billion | NT$6.32 Billion | NT$803.09 Million | ▲ +1.3 pp |
| 2021 | 51.5% | NT$5.41 Billion | NT$10.51 Billion | NT$5.97 Billion | NT$556.31 Million | ▲ +1.8 pp |
| 2020 | 49.7% | NT$5.23 Billion | NT$10.53 Billion | NT$5.92 Billion | NT$686.65 Million | ▲ +4.2 pp |
| 2019 | 45.5% | NT$4.66 Billion | NT$10.26 Billion | NT$5.41 Billion | NT$741.75 Million | ▲ +2.2 pp |
| 2018 | 43.3% | NT$4.56 Billion | NT$10.54 Billion | NT$6.51 Billion | NT$1.95 Billion | ▼ -8.1 pp |
| 2017 | 51.4% | NT$5.35 Billion | NT$10.42 Billion | NT$6.47 Billion | NT$1.12 Billion | ▲ +3.5 pp |
| 2016 | 47.8% | NT$4.89 Billion | NT$10.23 Billion | NT$6.59 Billion | NT$1.69 Billion | ▲ +9.7 pp |
| 2015 | 38.1% | NT$3.76 Billion | NT$9.86 Billion | NT$6.03 Billion | NT$2.27 Billion | ▲ +2.6 pp |
| 2014 | 35.5% | NT$3.33 Billion | NT$9.38 Billion | NT$5.25 Billion | NT$1.92 Billion | ▼ -9.8 pp |
| 2013 | 45.3% | NT$4.37 Billion | NT$9.64 Billion | NT$6.14 Billion | NT$1.77 Billion | ▼ -8.2 pp |
| 2012 | 53.5% | NT$4.85 Billion | NT$9.07 Billion | NT$6.06 Billion | NT$1.20 Billion | ▼ -5.0 pp |
| 2011 | 58.5% | NT$5.01 Billion | NT$8.56 Billion | NT$5.87 Billion | NT$857.79 Million | ▲ +6.4 pp |
| 2010 | 52.2% | NT$3.48 Billion | NT$6.68 Billion | NT$4.08 Billion | NT$595.31 Million | ▲ +5.5 pp |
| 2009 | 46.7% | NT$2.09 Billion | NT$4.47 Billion | NT$2.77 Billion | NT$682.53 Million | ▼ -15.7 pp |
| 2008 | 62.4% | NT$2.15 Billion | NT$3.44 Billion | NT$2.60 Billion | NT$455.55 Million | ▼ -8.8 pp |
| 2007 | 71.3% | NT$1.81 Billion | NT$2.53 Billion | NT$2.14 Billion | NT$333.25 Million | — |